What are the treatment options for onychomycosis (nail fungus)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Onychomycosis (Nail Fungus)

Terbinafine is the first-line oral treatment for dermatophyte onychomycosis due to its superior efficacy and fungicidal properties. 1

Diagnosis Before Treatment

  • Treatment should not be commenced before mycological confirmation of infection (KOH preparation, fungal culture, or nail biopsy) 1, 2
  • Dermatophytes are the most common causative organisms in onychomycosis 1
  • Yeasts and non-dermatophyte molds require careful interpretation as they may be secondary infections or saprophytes 1

Treatment Options Based on Pathogen

For Dermatophyte Onychomycosis:

Oral Treatments:

  • Terbinafine (first-line):

    • Dosage: 250 mg daily for 6 weeks (fingernails) and 12-16 weeks (toenails) 1
    • Mechanism: Inhibits squalene epoxidase in fungal cell wall synthesis, has fungicidal properties 1
    • Advantages: Higher cure rates (70-80% for toenails, 80-90% for fingernails), lower relapse rates 1
    • Monitoring: Baseline liver function tests and complete blood count recommended 1
    • Common side effects: Headache, taste disturbance, gastrointestinal upset 1
  • Itraconazole (alternative first-line):

    • Dosage options:
      • Continuous: 200 mg daily for 12 weeks 1
      • Pulse therapy: 400 mg daily for 1 week per month (2 pulses for fingernails, 3 pulses for toenails) 1
    • Best absorbed with food and acidic pH 1
    • Common side effects: Headache and gastrointestinal upset 1
    • Caution: Contraindicated in heart failure, monitor hepatic function 1
  • Fluconazole (alternative):

    • Dosage: 150-450 mg weekly for 3 months (fingernails) or at least 6 months (toenails) 1
    • Useful alternative when patients cannot tolerate terbinafine or itraconazole 1
  • Griseofulvin (not recommended as first-line):

    • Lower efficacy, higher relapse rates, and longer treatment duration compared to newer agents 1
    • Dosage: 500-1000 mg daily for 6-9 months (fingernails) or 12-18 months (toenails) 1

Topical Treatments:

  • Amorolfine 5% nail lacquer:

    • Applied once or twice weekly for 6-12 months 1
    • Most useful for superficial and distal onychomycosis 1
  • Ciclopirox 8% nail lacquer:

    • Applied daily for up to 48 weeks 1, 3
    • Requires monthly removal of unattached, infected nail by a healthcare professional 3
    • Complete cure rates are modest (5.5-8.5%) 3

For Candida Onychomycosis:

  • Itraconazole (first-line):

    • Most effective agent for candidal onychomycosis 1
    • Dosage: Same as for dermatophytes (400 mg daily for 1 week per month, 2 pulses for fingernails) 1
  • Fluconazole:

    • Alternative if itraconazole is contraindicated 1
    • Dosage: 50 mg daily or 300 mg weekly 1
  • Topical treatments:

    • Effective for most yeast infections, particularly those associated with paronychia 1
    • Imidazole lotion alternating with antibacterial lotion is usually effective 1

For Non-dermatophyte Mold Infections:

  • Itraconazole:
    • Broader antimicrobial coverage for non-dermatophyte molds 1
    • Particularly effective against Aspergillus species 1, 4
    • Clinical cure rates of 88% for single mold infections 4

Special Populations

Diabetic Patients:

  • Terbinafine preferred:
    • Lower risk of drug interactions and hypoglycemia 1
    • Itraconazole is contraindicated in congestive heart failure, which is more prevalent in diabetics 1

Immunosuppressed Patients:

  • Terbinafine or fluconazole preferred:
    • Lower risk of interactions with antiretrovirals compared to itraconazole 1
    • Griseofulvin is least effective in immunosuppressed patients 1

Prevention of Recurrence

  • Keep nails short and avoid sharing nail clippers 1
  • Wear protective footwear in public places (hotels, gyms, swimming pools) 1
  • Use antifungal powders containing miconazole, clotrimazole, or tolnaftate in shoes 1
  • Wear cotton, absorbent socks 1
  • Consider discarding contaminated footwear or treating with naphthalene mothballs 1

Common Pitfalls and Caveats

  • Treatment failure may occur due to:

    • Presence of dermatophytomas (dense white lesions beneath the nail) that require removal 1
    • Nail thickness >2mm, severe onycholysis, or slow nail growth 1
    • Poor compliance with lengthy treatment regimens 1
    • Misdiagnosis of the causative organism 1
  • Recurrence rates are high (40-70%), emphasizing the importance of preventive measures 1, 5

  • Follow-up should be at least 48 weeks (preferably 72 weeks) from the start of treatment to properly assess efficacy and identify relapses 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.